Showing results (6551-6560 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|February 3, 2007
Novel approaches for identification of broadly cross-reactive HIV-1 neutralizing human monoclonal antibodies and improvement of their potencyMei-Yun Zhang, Dimiter S DimitrovCurrent Pharmaceutical Design|February 3, 2007
Pharmacogenetics and drug therapy in psychiatry--the role of the CYP2D6 polymorphismP Vandel, J M Talon, E Haffen, et al.Current Pharmaceutical Design|February 22, 2007
Metallocarboxypeptidases: emerging drug targets in biomedicineJoan L Arolas, Josep Vendrell, Francesc X Aviles, et al.Current Pharmaceutical Design|February 22, 2007
Emerging roles of cysteine cathepsins in disease and their potential as drug targetsOlga Vasiljeva, Thomas Reinheckel, Christoph Peters, et al.Current Pharmaceutical Design|March 10, 2007
Dihydrofolate reductase as a target for chemotherapy in parasitesA Gangjee, S Kurup, O NamjoshiCurrent Pharmaceutical Design|March 10, 2007
The IGF axis in prostate cancerS Monti, L Proietti-Pannunzi, A Sciarra, et al.Current Pharmaceutical Design|March 14, 2007
Novel therapeutic approaches based on the targeting of microenvironment-derived survival pathways in human cancer: experimental models and translational issuesPierfrancesco Tassone, Pierosandro Tagliaferri, Maria Teresa Fulciniti, et al.Current Pharmaceutical Design|November 15, 2006
Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor alphaYoshio Kumazawa, Kiichiro Kawaguchi, Hiroaki TakimotoCurrent Pharmaceutical Design|July 14, 2007
Developing broadly reactive HIV-1/AIDS vaccines: a review of polyvalent and centralized HIV-1 vaccinesSean P McBurney, Ted M RossCurrent Pharmaceutical Design|July 14, 2007
Potential prophylactic and therapeutic vaccines for HSV infectionsSrividya Ramachandran, Paul R KinchingtonPageof 1,008